These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 6368735)
21. Lack of F1 anti-parental resistance in H-2b/d F1 hybrids devoid of beta2-microglobulin. Höglund P; Olsson-Alheim MY; Johansson M; Kärre K; Sentman CL Eur J Immunol; 1997 Jan; 27(1):342-5. PubMed ID: 9022038 [TBL] [Abstract][Full Text] [Related]
22. Mechanism of hybrid resistance. The role of a natural antibody in parental bone marrow cell rejection. Cabaniols JP; Bolonakis-Tsilivakos I; Cibotti R; Churaqui E; Duc HT; Halle-Pannenko O; Kosmatopoulos K J Immunol; 1991 Feb; 146(3):860-4. PubMed ID: 1988500 [TBL] [Abstract][Full Text] [Related]
23. Hybrid and allogeneic resistance to T cell grafts mediated by murine NK and CD8+ T cells. Davenport C; Haile A; Kumar V; Bennett M J Immunol; 1995 Mar; 154(6):2568-77. PubMed ID: 7876533 [TBL] [Abstract][Full Text] [Related]
24. Different sensitivities to hydrocortisone of natural killer cell activity and hybrid resistance to parental marrow grafts. Hochman PS; Cudkowicz G J Immunol; 1977 Dec; 119(6):2013-5. PubMed ID: 334980 [TBL] [Abstract][Full Text] [Related]
25. Polymorphism of Hh-1, the mouse hemopoietic histocompatibility locus. Rembecki RM; Kumar V; David CS; Bennett M Immunogenetics; 1988; 28(3):158-70. PubMed ID: 2457549 [TBL] [Abstract][Full Text] [Related]
26. Murine natural killer cells and marrow graft rejection. Yu YY; Kumar V; Bennett M Annu Rev Immunol; 1992; 10():189-213. PubMed ID: 1590985 [TBL] [Abstract][Full Text] [Related]
27. F1 hybrid anti-parental H-2k cell-mediated lympholysis. I. Stimulator and target determinants controlled by the H-2K region. Warner JF; Cudkowicz G J Immunol; 1979 Feb; 122(2):575-81. PubMed ID: 84028 [TBL] [Abstract][Full Text] [Related]
28. Implication of the H-2L locus in hybrid histocompatibility (Hh-1). Morgan GM; McKenzie IF Transplantation; 1981 Jun; 31(6):417-22. PubMed ID: 7020179 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules. Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631 [TBL] [Abstract][Full Text] [Related]
30. Target determinants for F1 hybrid anti-parental H-2d cell-mediated lympholysis: self antigens controlled by the D end. Nakamura I; Nakano K; Cudkowicz G J Immunol; 1983 May; 130(5):2429-33. PubMed ID: 6187857 [TBL] [Abstract][Full Text] [Related]
31. T killer cells play a role in allogeneic bone marrow graft rejection but not in hybrid resistance. Dennert G; Anderson CG; Warner J J Immunol; 1985 Dec; 135(6):3729-34. PubMed ID: 3905963 [TBL] [Abstract][Full Text] [Related]
32. Allospecificities of B6D2F1 hybrid NK cell subsets defined by Ly-49A expression. Basiri H; Kiura K; DeNardin EG; Nakamura I J Immunol; 1995 Sep; 155(6):2822-32. PubMed ID: 7673698 [TBL] [Abstract][Full Text] [Related]
33. Hybrid resistance against a natural killer (NK) cell-resistant lymphoma (YWA) is mediated by a T cell-dependent mechanism. Grönberg A; Klein GO; Kärre K; Kiessling R; Klein G Eur J Cancer Clin Oncol; 1982 Feb; 18(2):183-90. PubMed ID: 7201394 [TBL] [Abstract][Full Text] [Related]
34. Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCID). Evidence that natural killer cells can mediate the specificity of marrow graft rejection. Murphy WJ; Kumar V; Bennett M J Exp Med; 1987 Apr; 165(4):1212-7. PubMed ID: 3549961 [TBL] [Abstract][Full Text] [Related]
35. Bone marrow graft rejection as a function of antibody-directed natural killer cells. Warner JF; Dennert G J Exp Med; 1985 Mar; 161(3):563-76. PubMed ID: 2579185 [TBL] [Abstract][Full Text] [Related]
36. Aging of natural and acquired immunity of mice. I. Decreased natural killer cell function and hybrid resistance. Fitzgerald PA; Bennett M Cancer Invest; 1983; 1(1):15-24. PubMed ID: 6365265 [TBL] [Abstract][Full Text] [Related]
37. Hybrid resistance to parental bone marrow grafts in nonlethally irradiated mice. Mahr B; Pilat N; Granofszky N; Wiletel M; Muckenhuber M; Maschke S; Hock K; Wekerle T Am J Transplant; 2019 Feb; 19(2):591-596. PubMed ID: 30346652 [TBL] [Abstract][Full Text] [Related]
38. Hematopoietic histoincompatibility reactions by NK cells in vitro: model for genetic resistance to marrow grafts. Bordignon C; Daley JP; Nakamura I Science; 1985 Dec; 230(4732):1398-401. PubMed ID: 3906897 [TBL] [Abstract][Full Text] [Related]
39. The effects of polyinosinic:polycytidylic acid (pI:C) on the graft-vs-host (GVH) reaction. II. Increased NK-mediated rejection on C57BL/6 lymphocytes by (C57BL/6 X A)F1 mice. Peres A; Nestel FP; Seemayer TA; Lapp WS J Immunol; 1986 Dec; 137(11):3420-7. PubMed ID: 3537120 [TBL] [Abstract][Full Text] [Related]
40. In vivo natural antitumor resistance against murine EL-4 lymphoma cells in lethally irradiated syngeneic C57Bl/6 mice. Iorio AM; Neri M; Bonmassar E; Titti F; Rossi GB Cell Immunol; 1987 Aug; 108(1):85-96. PubMed ID: 3607887 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]